Protherics PLC announces Issue of Shares
July 04 2008 - 12:04PM
Marketwired
CHESHIRE, UK , the international biopharmaceutical company
focused on critical care and cancer, announces that the Company has
today issued 1,741,911 ordinary shares pursuant to the MacroMed
Acquisition Agreement ("Agreement") approved by shareholders at the
Company's Extraordinary General Meeting held on 3 January 2007 and
details of which were contained in the Company's announcement dated
7 December 2006. Under the terms of the Agreement 10% of the
ordinary shares issuable upon the acquisition of MacroMed Inc. were
held back for a period of 18 months from the date of the
Acquisition and have become issuable on the basis that no claims
against the MacroMed vendors have arisen over that period.
Accordingly, application has today been made to the UK Listing
Authority of the London Stock Exchange for the listing of 1,741,911
ordinary shares of 2p each in the Company. The Shares will rank
equally with the existing issued ordinary shares of the Company and
are expected to be admitted to the Official List and commence
trading on or around 9 July 2008. Following admission of these
ordinary shares, the Company's issued share capital will be
342,159,034 ordinary shares. / Ends / For further information
please contact: Protherics Nick Staples, Director of Corporate
Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44
(0)1928 518000 Financial Dynamics - press enquiries London: Ben
Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno,
Jonathan Birt +1 212 850 5600 Or visit www.protherics.com This
information is provided by RNS The company news service from the
London Stock Exchange END
Contacts: RNS Customer Services 0044-207797-4400 Email Contact
http://www.rns.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Jul 2023 to Jul 2024